Gts Securities »

Amylyx Pharmaceuticals shares owned by Gts Securities

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 385k 2.84
2023-12-31 $610k 41k 14.72
2023-09-30 $472k 26k 18.31

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Broadcom Put Option (AVGO)
Advanced Micro Devices Put Option (AMD)
Microstrategy Cl A New Put Option (MSTR)

View all positions for Gts Securities

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
Millennium Management
Citadel Advisors
Morgan Stanley
Perceptive Advisors
Franklin Resources
Ikarian Capital
Boxer Capital
Susquehanna International
Two Sigma Investments
Farallon Capital Management
Geode Capital Management
D. E. Shaw & Co

View all funds holding Amylyx Pharmaceuticals